HealthLynked Corp.
HealthLynked Corp. (HLYK) Stock Overview
Explore HealthLynked Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
7.9M
P/E Ratio
-1.59
EPS (TTM)
$-0.02
ROE
1.42%
HLYK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of HealthLynked Corp. (HLYK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.04.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.59 and a market capitalization of 7.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.